The largest database of trusted experimental protocols

179 protocols using cytofix cytoperm fixation permeabilization solution kit

1

Immunofluorescence Analysis of Phospho-Kinases

Check if the same lab product or an alternative is used in the 5 most similar protocols
HR1R2F cells cultured in 96-well plates were starved in serum-free DMEM for 16 hrs, followed by treatment with 0.5 μM fMLF for 20 min. Cells were fixed and the immunofluorescence was assessed following staining with Becton Dickinson Cytofix/Cytoperm Fixation/Permeabilization Solution Kit following the manufacturer’s protocol. Phospho-PKD/PKμ (Ser 744/748), phospho-PKCα/β II (Thr638/641), phospho-PKCδ (Thr505); phospho-PKC θ (Thr538), phospho-PKC ζ/λ (Thr410/403) (Cell signaling technology Inc.) were prepared in the BD washing buffer and added to the cells at 4°C, then stained with alexa-488 labeled secondary antibodies for 2 hrs at 4°C, and imaged with a Nikon inverted fluorescence microscope using a 20× objective lens.
+ Open protocol
+ Expand
2

Flow Cytometric Analysis of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
LP and MLN cells were assessed by FACS for specific surface markers using PE-conjugated anti-CD11c (1:100, Biolegend, cod. 117308), FITC-conjugated anti-CD103 (1:100, Biolegend, cod. 121419), FITC-conjugated anti-CCR7 (1:100, Serotec, cod. MCA2367F), APC-conjugated anti-CD3 (1:100, Miltenyi, cod. 130-117-793) Pacific Blue-conjugated anti-CD4 (1:100, Biolegend, cod. 100428), and FITC-conjugated anti-CCR9 (1:100, Miltenyi, cod. 130-115-602) antibodies. Cells (5 × 105) were resuspended in 100 μl PBS containing 0.5% BSA and stained with the antibodies for 20 min at room temperature. Intracellular staining on LP and MLN cells was performed using Cytofix/Cytoperm, Fixation/Permeabilization Solution Kit (Becton–Dickinson), according to the manufacturer’s protocol. Briefly, cells were incubated with FITC-conjugated anti-CD4 and APC-conjugated anti-CD25 (1:100, Biologend, cod. 101709) antibodies, fixed/permeabilized for 15 min at 4°C, and processed for intracellular staining using PE-conjugated anti-FoxP3 antibody (1:100, Biolegend, cod. 126403) for 30 min at 4°C. Data were acquired on a FACS Canto II (Becton–Dickinson) and analyzed using DIVA 6.1 software.
+ Open protocol
+ Expand
3

Cytokine Production in Ly49H+ NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ly49H+ NK cells were sorted from CD45.1 splenocytes as described into a 96-well U-bottom plate containing 400.000 C57BL/6 splenocytes per well in cRPMI. After sorting, Phorbol-12-myristat-13-acetat (PMA) and ionomycin (Sigma-Aldrich) were added at a final concentration of 20 ng/mL and 1.25 μg/mL, respectively. An equal volume of DMSO, diluted 1/10 in cRPMI, was added to the negative control. After one h, Golgi Plug™ (Beckton Dickinson) was added 1/1000 to the culture. 4 h later, cells were washed with FACS buffer and life/dead discrimination as well as staining of surface molecules was performed as described. Intracellular cytokine staining was done according to the manufacturer’s instructions using Cytofix/Cytoperm™ Fixation/ Permeabilization Solution Kit (Beckton Dickinson).
+ Open protocol
+ Expand
4

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleen cell suspensions from each mouse were obtained by dissociation of tissue and red blood cells were lysed with 0.85% ammonium chloride solution. To analyze T cells subsets, one million splenocytes were stained for 15 minutes with the following antibodies: anti-CD3-BV605, anti-CD4-PerCP-Cy5.5, anti-CD44-PE-Cy7 and anti-CD62L-APC (BD Biosciences). After incubation, the cells were washed with PBS and fixed with 1% formaldehyde in PBS. To analyze Treg cells, 1X106 splenocytes were stained with anti-CD3-BV421, anti-CD4-APC and anti-CD25-APC-Cy7. To detect intracellular FoxP3 expression, cells were permeabilized (Cytofix/Cytoperm TM Fixation/Permeabilization Solution Kit, BD Biosciences) and anti-FoxP3-Alexa488 was added and incubated for 30 minutes. Data were acquired in BD LRS Fortessa flow cytometer (Becton-Dickinson, San Jose, CA) and analyzed by FlowJo software (FlowJo, Tree Star, Ashland, OR).
+ Open protocol
+ Expand
5

Quantifying Cell Proliferation by Ki67

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were acquired using the Cytofix/CytopermTM Fixation/Permeabilization Solution Kit (BD Biosciences), and then the percentage of Ki67-positive cells was determined. Anti-Ki67 antibody was added (1:500), and the group of tubes without antibody was used as the control. Antibody against Ki67 and antibody against rabbit immunoglobin G (IgG); H+L; Phycoerythrin (PE) were obtained from Abcam.
+ Open protocol
+ Expand
6

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For surface staining, cells were stained with anti-CD3 PerCP-Cy5.5, anti-CD4 APC, anti-CD25 APC-Cy7, anti-CD69 Pe-Cy7, anti-PD-1 BV421, and anti-CD38 Alexa Fluor 488 (all from BD Biosciences, San Diego, CA, USA). Cells were then incubated for 15 minutes under room temperature and were fixed with 1% formaldehyde for 15 minutes. For intracellular staining, cells were permeabilized (Cytofix/Cytoperm TM Fixation/Permeabilization Solution Kit, BD Biosciences) for 40 minutes and stained with anti-FoxP3 Alexa Fluor 488, anti-CTLA-4 BV605, and anti-IL-10 APC. All the samples were analyzed using an LSRFortessa flow cytometer (Becton-Dickinson, San Jose, CA, USA) and analyzed by FlowJo software (FlowJo, Tree Star, Ashland, OR, USA).
+ Open protocol
+ Expand
7

Cytokine Profiling of Antigen-Specific T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Assays were performed as previously described with modification (22 , 25 (link)). Single cell suspensions were prepared from spleens on d21 post-immunization as described. Cells (5 × 105/ml) were plated in HL-1 media (Lonza) containing 2mM glutamine and 100 U/ml penicillin-strepotmycin (Invitrogen Life Technologies). After 48 h stimulation with 20 μg/ml whole IRBP protein, cells were stimulated in the presence of 20 ng/ml PMA (LC Labs), 200 ng/ml ionomycin (LC Labs, Woburn, MA), and brefeldin A (BD GolgiPlug; BD Biosciences) for 4h at 37°C prior to fixation/permeabilization using BD Cytofix/CytopermTM Fixation/Permeabilization solution Kit (BD Biosciences). Cells were stained with fluorescently-conjugated antibodies to CD45, CD4, CD8, IFNγ, and IL-17A. Flow cytometry with a BD LSRFortessa (BD Biosciences) was used to collect a total of 300,000 CD45+ events. Dead cells were excluded based on Viability Dye eFluor® 506 (eBioscience) staining and live CD45+CD4+ gated cells were further evaluated for the frequency of IFNγ, IL-17A, or double-positive cells. Data were analyzed with FCS Express (De Novo Software) based on compensation and gating criteria described above.
+ Open protocol
+ Expand
8

Immunophenotyping of Macrophage Surface Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were harvested by treatment with 0.1% trypsin-EDTA, and detached cells were washed with cold PBS (pH 7.3). The cells were labeled with FITC-conjugated antibodies CD206 or CD68 or CD14, and PE-conjugated antibody CD204 (Abcam, USA). For CD68 staining, the cells were fixed and permeabilized with a BD Cytofix ⁄CytopermTM Fixation ⁄ Permeabilization Solution Kit (BD Biosciences, USA). Cells were then incubated with FITC-CD68 mAb. For surface markers (CD14, CD206, and CD204), the cells were incubated with FITC-CD14, FITC-CD206 or PE-CD204 mAb without permeabilization step. The cells were examined using a FACSCanto II cytometer (BD Biosciences, Germany), and the data were analyzed using FlowJo software (FlowJo, USA).
+ Open protocol
+ Expand
9

Intracellular Flow Cytometry for CHIKV Antiviral Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antiviral activity of the LQM334 compound was confirmed by intracellular flow cytometry staining [119 (link)]. Briefly, after CHIKV adsorption in Vero E6 cells for 2 h, the medium was removed, the cell monolayer was washed with PBS. The LQM334 compound was added at 20 or 40 μM concentrations and the cells were maintained at 37 °C/5% CO2 atmosphere for 48h. The cells were detached by using a trypsin/EDTA solution and submitted to fixation and permeabilization using the BD Cytofix/ CytopermTM Fixation/Permeabilization solution kit (BD Biosciences®, San Jose, CA, USA) according to the manufacturer’s recommendations. Subsequently, the cells were incubated with an anti-CHIKV monoclonal antibody (1:50; A54Q clone; Invitrogen, Carlsbad, CA, USA) for 1h at 4 °C. The cells were washed with the BD Perm Wash solution (BD Biosciences®, San Jose, CA, USA) and then incubated with the goat anti-mouse IgG (H + L) cross-adsorbed secondary antibody conjugated with Alexa Fluor 488 (1:200; Invitrogen) for 1h at 4 °C. A total of 20,000 events were acquired in the BD FACS CantoTM II flow cytometer (BD Biosciences®, San Jose, CA, USA) and the results were analyzed by using FlowJoTM v. 10 software.
+ Open protocol
+ Expand
10

Cytokine Production Analysis by Intracellular Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytokine production was analyzed by intracellular staining (ICS) assay. PBMCs were incubated with or without the relevant peptides (20 μg/ml) plus anti-CD28 mAb (4 μg/ml) (BD Biosciences) and the Protein Transport Inhibitor Cocktail (Brefeldin A and Monensin; eBioscience), or with the Cell Stimulation Cocktail (phorbol 12-myristate 13-acetate [PMA], ionomycin, brefeldin A, and monensin; eBioscience) as a positive control, for 18 h at 37°C [16 (link),22 (link)]. Cells were washed and then stained with APC-labeled—HLA-A*0201 dextramers complexed to corresponding peptides, PeCy7-labeled mAb to CD8 (BioLegend), and the dump channel reagents. Cells were fixed and permeabilized using the BD Cytofix/Cytoperm Fixation/Permeabilization Solution Kit (BD Biosciences) at 4°C for 20 min, rewashed with the BD Perm/Wash buffer (BD Biosciences), and stained with different combinations of AlexaFluor700-labeled IL-17A (BioLegend) and FITC-labeled anti-IFN-γ (BioLegend) for 20 min at 4°C. Cells were washed, acquired with the LSRFortessa cytometer, and analyzed with FlowJo software. IL-17, IFN-γ or IL-17/IFN-γ producing cells were analyzed in CD8+dextramer+ cells after exclusion of B cells, monocytes, NKT cells, NK cells, and CD4+ T cells (dump channel).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!